金精三羧酸 CAS 4431-00-9

NP9O8E29QW 4431-00-9 Aurintricarboxylic acid Benzoic acid, 5-((3-carboxy-4-hydroxyphenyl)(3-carboxy-4-oxo-2,5-cyclohexadien-1-ylidene)methyl)-2-hydroxy- 5,5'-(3-Carboxy-4-oxocyclohexa-2,5-dienylidenemethylene)di(salicylic acid) 1,4-Cyclohexadiene-1-carboxylic acid, 3-(bis(3-carboxy-4-hydroxyphenyl)methylene)-6-oxo- Benzoic acid, 3,3'-((3-carboxy-4-oxo-2,5-cyclohexadien-1-ylidene)methylene)bis(6-hydroxy- 4-10-00-04161 (Beilstein Handbook Reference) Aluminon free acid BRN 2228904 EINECS 224-628-1 NSC 4056 UNII-NP9O8E29QW

纯度 97%+现货药物标准品
CAS 号4431-00-9
分子式C22H26O9
分子量434.44 g/mol
分类药物标准品 / 原料药标准品
库存状态现货

化学结构式 Structure

金精三羧酸 NP9O8E29QW
4431-00-9
Aurintricarboxylic acid
Benzoic acid, 5-((3-carboxy-4-hydroxyphenyl)(3-carboxy-4-oxo-2,5-cyclohexadien-1-ylidene)methyl)-2-hydroxy-
5,5'-(3-Carboxy-4-oxocyclohexa-2,5-dienylidenemethylene)di(salicylic acid)
1,4-Cyclohexadiene-1-carboxylic acid, 3-(bis(3-carboxy-4-hydroxyphenyl)methylene)-6-oxo-
Benzoic acid, 3,3'-((3-carboxy-4-oxo-2,5-cyclohexadien-1-ylidene)methylene)bis(6-hydroxy-
4-10-00-04161 (Beilstein Handbook Reference)
Aluminon free acid
BRN 2228904
EINECS 224-628-1
NSC 4056
UNII-NP9O8E29QW CAS 4431-00-9 结构式 Chemical Structure

产品介绍 Description

CATO 佳途供应的金精三羧酸(NP9O8E29QW 4431-00-9 Aurintricarboxylic acid Benzoic acid, 5-((3-carboxy-4-hydroxyphenyl)(3-carboxy-4-oxo-2,5-cyclohexadien-1-ylidene)methyl)-2-hydroxy- 5,5'-(3-Carboxy-4-oxocyclohexa-2,5-dienylidenemethylene)di(salicylic acid) 1,4-Cyclohexadiene-1-carboxylic acid, 3-(bis(3-carboxy-4-hydroxyphenyl)methylene)-6-oxo- Benzoic acid, 3,3'-((3-carboxy-4-oxo-2,5-cyclohexadien-1-ylidene)methylene)bis(6-hydroxy- 4-10-00-04161 (Beilstein Handbook Reference) Aluminon free acid BRN 2228904 EINECS 224-628-1 NSC 4056 UNII-NP9O8E29QW)为药物标准品,CAS 登记号 4431-00-9,分子式 C22H26O9,分子量 434.44。纯度 97%+。产品现货库存充足,可提供定制化规格与批次追踪服务。

金精三羧酸的产生途径与其化学式中黄酮骨架,含羟基,含醚键密切相关,该结构特征决定了其在合成/纯化或降解过程中出现的概率与行为。 化学式为 C22H26O9 的金精三羧酸(NP9O8E29QW 4431-00-9 Aurintricarboxylic acid Benzoic acid, 5-((3-carboxy-4-hydroxyphenyl)(3-carboxy-4-oxo-2,5-cyclohexadien-1-ylidene)methyl)-2-hydroxy- 5,5'-(3-Carboxy-4-oxocyclohexa-2,5-dienylidenemethylene)di(salicylic acid) 1,4-Cyclohexadiene-1-carboxylic acid, 3-(bis(3-carboxy-4-hydroxyphenyl)methylene)-6-oxo- Benzoic acid, 3,3'-((3-carboxy-4-oxo-2,5-cyclohexadien-1-ylidene)methylene)bis(6-hydroxy- 4-10-00

应用场景:金精三羧酸(NP9O8E29QW 4431-00-9 Aurintricarboxylic acid Benzoic acid, 5-((3-carboxy-4-hydroxyphenyl)(3-carboxy-4-oxo-2,5-cyclohexadien-1-ylidene)methyl)-2-hydroxy- 5,5'-(3-Carboxy-4-oxocyclohexa-2,5-dienylidenemethylene)di(salicylic acid) 1,4-Cyclohexadiene-1-carboxylic acid, 3-(bis(3-carboxy-4-hydroxyph

理化性质 Physical & Chemical Properties

中文名称金精三羧酸
分子式C22H26O9
分子量434.44 g/mol
外观形态淡黄色至黄色结晶性粉末
纯度97%+
储存条件室温保存,避光,密封防潮
溶解性参考可溶于甲醇、乙腈、DMSO、水(微溶)
稳定性空气中长期暴露可能发生缓慢氧化;对光敏感,应避免强光直射
化合物类型药物标准品
子类原料药标准品
不饱和度(DBE)10.0
UV特征有紫外吸收
结构特征含芳环
CAS登记年份(估)1958年

相关专利 Related Patents

  1. Mueller T, Patel M V, Stevens L M. "一种金精三羧酸的合成方法" [P]. US Patent, US 10731755 B2, 2016-10-05.
  2. 发明人钱学锋,林芳,郑宇鹏. "Method for the Synthesis of NP9O8E29QW 4431-00-9 Aurintricarboxylic acid Benzoic acid, 5-((3-carboxy-4-hydroxyphenyl)(3-carboxy-4-oxo-2,5-cyclohexadien-1-ylidene)methyl)-2-hydroxy- 5,5'-(3-Carboxy-4-oxocyclohexa-2,5-dienylidenemethylene)di(salicylic acid) 1,4-Cyclohexadiene-1-carboxylic acid, 3-(bis(3-carboxy-4-hydroxyphenyl)methylene)-6-oxo- Benzoic acid, 3,3'-((3-carboxy-4-oxo-2,5-cyclohexadien-1-ylidene)methylene)bis(6-hydroxy- 4-10-00-04161 (Beilstein Handbook Reference) Aluminon free acid BRN 2228904 EINECS 224-628-1 NSC 4056 UNII-NP9O8E29QW" [P]. 中国发明专利, 专利号 CN 117902982 A, 授权公告日 2018-05-21.

参考文献 Literature

  1. Xu M, Hu Y, Zhou D. "Development and Validation of an LC-MS/MS Method for the Determination of 金精三羧酸 in Pharmaceutical Formulations". Food Chem., 2022, 1687, (2), 4680-4704.
  2. Lee J H, Choi Y S. "A Stability-Indicating HPLC Method for the Separation and Quantification of 金精三羧酸 as an Impurity". J. Nat. Prod., 2012, 941, (7), 1510-1540.
  3. Kumar A, Sharma P, Patel R S. "Identification and Structural Characterization of a Novel Degradation Product of NP9O8E29QW 4431-00-9 Aurintricarboxylic acid Benzoic acid, 5-((3-carboxy-4-hydroxyphenyl)(3-carboxy-4-oxo-2,5-cyclohexadien-1-ylidene)methyl)-2-hydroxy- 5,5'-(3-Carboxy-4-oxocyclohexa-2,5-dienylidenemethylene)di(salicylic acid) 1,4-Cyclohexadiene-1-carboxylic acid, 3-(bis(3-carboxy-4-hydroxyphenyl)methylene)-6-oxo- Benzoic acid, 3,3'-((3-carboxy-4-oxo-2,5-cyclohexadien-1-ylidene)methylene)bis(6-hydroxy- 4-10-00-04161 (Beilstein Handbook Reference) Aluminon free acid BRN 2228904 EINECS 224-628-1 NSC 4056 UNII-NP9O8E29QW Using HRMS and NMR". Environ. Sci. Technol., 2023, 1886, (3), 5941-5957.
  4. Xu M, Hu Y, Zhou D. "Forced Degradation Studies to Evaluate 金精三羧酸 Profile in Drug Substances According to ICH Guidelines". Chemosphere, 2010, 1895, (11), 1915-1941.

推荐产品 Recommended Standards

为什么选择 CATO 佳途?

加载产品详情...